MARKER THERAPEUTICS INC (MRKR:NASDAQ)
$0.98 -0.03 (-2.9703%)
Analysed MARKER THERAPEUTICS INC (MRKR:NASDAQ) News Sources
3 High Growth Tech Stocks To Watch In The US Market
02-06-2026
yahoo.com
US High Growth Tech Stocks with Promising Potential
05-06-2026
yahoo.com
Exploring 3 High Growth Tech Stocks In The US Market
05-06-2026
yahoo.com
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
26-06-2026
yahoo.com
Aurinia Pharmaceuticals (AUPH) Surpasses Q2 Earnings Estimates
06-08-2026
yahoo.com
High Growth Tech Stocks To Watch In US June 2026
03-06-2026
yahoo.com
Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies
22-09-2026
yahoo.com
New Strong Buy Stocks for October 16th
16-10-2026
yahoo.com
All You Need to Know About MARKER THERAPEUTICS (MRKR) Rating Upgrade to Strong Buy
16-10-2026
yahoo.com
Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer
19-10-2026
yahoo.com
What is the current price of MARKER THERAPEUTICS INC (MRKR:NASDAQ)?
The current price of MARKER THERAPEUTICS INC (MRKR:NASDAQ) is $0.98.
MARKER THERAPEUTICS INC (MRKR:NASDAQ) absolute price change since previous trading day?
The absolute price change of MARKER THERAPEUTICS INC (MRKR:NASDAQ) since the previous trading day is $-0.03.
MARKER THERAPEUTICS INC (MRKR:NASDAQ) percentage price change since previous trading day?
The percentage price change of MARKER THERAPEUTICS INC (MRKR:NASDAQ) since the previous trading day is -2.9703%.
What is the most recent average sentiment score for MARKER THERAPEUTICS INC (MRKR:NASDAQ)?
The most recent average sentiment score for MARKER THERAPEUTICS INC (MRKR:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for MARKER THERAPEUTICS INC (MRKR:NASDAQ)?
The most recent sentiment for MARKER THERAPEUTICS INC (MRKR:NASDAQ) is .
SEC-8K** Filing Available For MARKER THERAPEUTICS INC (MRKR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.